Caterina De Rosa

7PUBLICATIONS
33CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 04, 2026
The evolving landscape of first-line and subsequent therapies in EGFR-mutated NSCLC: efficacy, resistance, and tolerability.

|Dec 11, 2025
Effect of Soluble Factors Released from Porcine Freeze-Dried Lung Tissue (FDLT) on Modulation of Cell Growth and EMT Signature in Non-Small Cell Lung Cancer (NSCLC)-A Preliminary In Vitro Study.

Umme Samia, Daniela Omodei, Luisa Amato

|Jul 29, 2025
Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System.

Hamid Heydari Sheikhhossein, Luisa Amato, Viviana De Rosa

|Dec 17, 2024
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer.

Luisa Amato, Daniela Omodei, Caterina De Rosa

|Nov 08, 2024
Discovery of N-substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer.

Stefano Tomassi, Benito Natale, Michele Roggia

|Sep 28, 2024
Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study.

Luisa Amato, Caterina De Rosa, Viviana De Rosa

Pageof 2

Frequent Collaborators

6 joint publications

Carminia Maria Della Corte

5 joint publications

Francesca Iommelli

5 joint publications

Viviana De Rosa

5 joint publications

Luisa Amato